Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05293912
Title SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hangzhou Sumgen Biotech Co., Ltd.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.